台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
易威 (1799)籌碼相關-元富-城中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-城中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/0600.00164.5065.10-1623-0.16%
2025/01/0300.00262.6062.60-2631-0.32%
2025/01/0200.00164.2064.20-1643-0.16%
2024/12/31163.9000.0064.3016690.15%
2024/12/3000.00165.8066.70-1692-0.14%
2024/12/27263.5000.0063.3026970.29%
2024/12/26170.2000.0066.6016920.14%
2024/12/25174.20174.3074.0006830.00%
2024/12/24170.3000.0073.0016770.15%
2024/11/25172.8000.0071.9016810.15%
2024/11/2000.00168.0067.40-1666-0.15%
2024/11/18166.4000.0067.0016760.15%
2024/11/1100.001070.1070.10-10606-1.65%
2024/11/0500.00984.4084.90-9636-1.41%
2024/11/0400.00590.5291.80-5637-0.78%
2024/11/0100.00492.4891.50-4653-0.61%
2024/10/2900.001195.0996.40-11679-1.62%
2024/10/2200.004103.13107.00-4726-0.55%
2024/10/1100.001119.00114.50-1824-0.12%
2024/10/094120.001115.00119.0038380.36%
2024/10/0710115.0000.00116.50108301.20%
2024/10/044104.6300.00106.5048130.49%
2024/10/0100.00799.9797.20-7787-0.89%
2024/09/3000.007108.00108.00-7777-0.90%
2024/09/2700.004121.50120.00-4796-0.50%
2024/09/255146.1000.00147.5057840.64%
2024/09/231152.5000.00158.0017940.13%
2024/09/061195.0000.00195.0018000.12%
2024/09/041208.5000.00207.0018020.12%
2024/08/2800.004213.00210.00-4788-0.51%
2024/08/2300.002225.50229.00-2798-0.25%
2024/08/201206.0000.00216.0018060.12%
2024/08/1900.001201.50201.50-1820-0.12%
2024/08/165199.002193.00200.5038220.36%
2024/08/1500.0010193.05191.50-10827-1.21%
2024/08/141190.5000.00192.0018410.12%
2024/08/133192.1700.00189.0038430.36%
2024/08/091181.5000.00203.5018240.12%
2024/08/083186.8300.00187.0037940.38%
2024/08/0500.004173.38180.00-4768-0.52%
2024/08/0200.004183.00177.50-4749-0.53%
2024/07/221.1164.0000.00164.001.16670.16%
2024/07/193177.8300.00182.0036500.46%
2024/07/178177.8800.00191.0085891.36%
2024/07/1500.001163.00164.50-1554-0.18%
2024/07/081135.0000.00138.5014930.20%
2024/07/031126.0000.00124.5014740.21%
2024/07/0200.006135.17138.00-6446-1.34%
2024/06/286120.5000.00130.0064131.45%
2024/06/1900.002103.75101.50-2374-0.53%
2024/06/181106.5000.00104.5013640.27%
2024/05/3100.00194.1091.80-1317-0.31%
2024/05/3000.00592.1690.90-5320-1.56%
2024/05/2910101.2000.0094.50103193.13%
2024/05/271100.0000.00100.0013070.33%
2024/05/24199.5000.00105.0012980.33%
2024/05/21189.8000.0093.0012500.40%
2024/05/20283.1000.0086.3022380.84%
2024/03/1500.00158.0058.60-1225-0.44%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音